<DOC>
	<DOCNO>NCT00450268</DOCNO>
	<brief_summary>We plan investigate prospectively simultaneously skin blood DC subtypes , donor/recipient origin correlation DC reconstitution kinetics treatment , clinical outcome incidence aGvHD patient undergo allogeneic hematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Dendritic Cells Patients Following Allogeneic Hematopoietic Stem Cell Transplantation</brief_title>
	<detailed_description>Blood skin DC reconstitution shall investigate patient affected hematological disease receive HLA-matched , mobilize peripheral blood stem cell relate unrelated donor . We plan simultaneously collect process double biopsy , i.e . graft versus host disease affect non-lesional skin patient onset acute graft versus host disease follow allogeneic hematopoietic stem cell transplantation . Emigration assay , Chimerism analysis immunohistochemistry perform .</detailed_description>
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Patient undergo allogeneic hematopoietic stem cell transplantation Older 18 year WHOPerformanceStatus 0 to3 Informed consent Graft versus host disease skin Clotting parameter double normal Infection skin Leucocytes &lt; 1000/µl ; Thrombocytes &lt; 20 000/µl</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Graft versus host disease</keyword>
	<keyword>Allogeneic hematpoietic stem cell transplantation</keyword>
</DOC>